The Current Ratio of Lyell Immunopharma Inc (LYEL) is 7.06.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date | Value |
|---|---|
| 2024-12-31 | 7.06 |
| 2023-12-31 | 16.07 |
| 2022-12-31 | 17.60 |
| 2021-12-31 | 13.41 |
| 2020-12-31 | 12.53 |
| 2019-12-31 | 20.01 |